Construction of Recombinant Vector on Il-24 and Its Effect in Combination with Chemotherapy Drugs for Tubb3 and Ercc-1 Expression in Skov3 Cells

祝贺,杜珍武,范丽梅,高海成,崔满华
DOI: https://doi.org/10.7503/cjcu20140975
2015-01-01
Abstract:Gene fragments of IL-24 were cloned into pcDNA3. 0-OSP-1-IL-24 and pcDNA3. 0-IL-24 vector using gene recombination technology, the expression of two vectors was measured by RT-PCR methods. The two chemotherapy drugs of paclitaxel and cisplatin were applied into normal SKOV3 cells, stable transfected SKOV3 cells of pcDNA3. 0, PcDNA3.0-IL-24, pcDNA3. 0-OSP-1 and pcDNA3. 0-OSP-1-IL-24, respectively. The cell killing effect and proliferation ability of IL-24 in combination with chemotherapy drugs were detected by 3-(4, 5)-dimethylthiahiahiazo-(z-yl)-2,5-di-phenytetrazolium,bromide (MTT) in SKOV3 cells. Gene expression of TUBB3 and ERCC-1 were detected by real-time fluorescent quantitative polymerase chain reaction(PCR) technology in cell of each group. RT-PCR results showed that the pcDNA3. 0-IL-24 and pcDNA3. 0-OSP-1-IL-24 vector were cloned successfully by gene recombination technology. IL-24 gene can increase the sensitivity of SKOV3 cells to chemotherapeutic drug of cisplatin and paclitaxel. Its combination with chemotherapy drugs for IC50 of tumor drugs decreased 10 times and 6 times, respectively. Gene expression of TUBB3 gene and ERCC-1 decreased 4 times and 10 times, respectively. These results suggested that IL-24 in combination with chemotherapy drugs could reduce gene expression of TUBB3 and ERCC-1. This experiment provided an important theory basis for the clinical treatment of ovarian cancer.
What problem does this paper attempt to address?